HOME >> BIOLOGY >> NEWS
Only 21 states offer newborn screening tests recommended by March of Dimes

WHITE PLAINS, N.Y., JUNE 30, 2004 Seventy percent of babies born in the U.S. still fail to get the minimal number of newborn tests recommended by the March of Dimes, according to the non-profit's 2004 state-by-state report card on newborn screening.

The March of Dimes is the first national health organization to recommend that every baby born in the U.S. receive, at a minimum, screening for the same core group of nine metabolic disorders as well as hearing deficiency. The March of Dimes encourages states to add more screening tests as resources and capabilities allow.

Few parents realize that the extent of this testing depends entirely on the state in which their baby is born. These tests can sometimes mean the difference between a healthy start in life and disability, or even death, the March of Dimes says.

"The number of screened disorders continues to vary greatly by state. Here we have a simple and inexpensive solution to a potentially devastating problem, and it's time for all states to make newborn screening a top priority," says Dr. Jennifer L. Howse, president of the March of Dimes and a member of the U.S. Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children.

"Our chapter staff and volunteers have been working closely with governors, state legislators, and health departments to increase access to these important tests," Dr. Howse says. "I'm encouraged to report today that since this time last year, the number of states that test for the nine core metabolic disorders has risen from nine to 21."

Currently, 21 states screen for the March of Dimes-recommended list of metabolic disorders: Alaska, Connecticut, Hawaii, Idaho, Illinois, Indiana, Iowa, Maine, Maryland, Massachusetts, Mississippi, Nevada, New York, North Dakota, Oregon, Rhode Island, Tennessee, Vermont, Virginia, Washington, and Wisconsin. In 2002, these states accoun
'"/>

Contact: Michele Kling
mkling@marchofdimes.com
914-997-4613
March of Dimes Birth Defects Foundation
30-Jun-2004


Page: 1 2 3

Related biology news :

1. Alternative states in the ocean
2. Mathematical models reveal molten and glassy states of RNA
3. Not all enlarged prostates are the same, say University of Pittsburgh researchers
4. Canine leishmaniasis cases are confirmed in 21 states
5. Genetic extremism overstates risks
6. Lake research offers clues to managing crayfish invasions
7. Comparing primate genomes offers insight into human evolution
8. UW study: Migrating birds offer insight into sleep
9. Study of proteins offers insights into organization of biological networks
10. Susceptibility of mice to mousepox offers promise of smallpox protection
11. Discovery in parasite movement may offer insights into malaria

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Only states offer newborn screening tests recommended March Dimes

(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... -- According to a new market ... Technology, Material (Optical Prism, Piezoelectric, Capacitive & Adhesives), ... & Geography - Global Forecast to 2014 - ... expected to reach $14,500.07 Million by 2020, at ... 76 market Tables and 109 Figures spread through ...
(Date:6/24/2015)... YORK , June 24, 2015 The ... rate. The major drivers for the market include growth ... number of new drug launches. Over the years, the ... increased. Between 2001 and 2010, the FDA approved 225 ... according to WIPO, Europe accounted ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
(Date:7/1/2015)... 2015   Decision Resources Group finds ... Otezla are its oral administration, alternative mechanism of ... surveyed rheumatologists. Otezla was the first oral therapy ... active psoriatic arthritis in the United ... includes conventional oral treatments including disease-modifying antirheumatic drugs ...
(Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
(Date:7/1/2015)... 1, 2015  Axovant Sciences Ltd. (NYSE:  AXON), ... treatment of dementia, today announced that the company ... at 5:45 p.m. EDT following its presentation of ... Conference 2015 (AAIC). The event ... Dr. Lawrence Friedhoff , Chief Development Officer, ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan contest will ask ... to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will ... and a period of expert mentorship from a senior industry figure drawn from the ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: